Skip to content
healthcare.dev

BEOVU

NDC 0078-0827, brolucizumab, injection, solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0827
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761125
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0827 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BROLUCIZUMAB6 mg/.05mL
Package NDCNDC-11Package
0078-0827-60000780827601 SYRINGE, GLASS in 1 CARTON (0078-0827-60) / .05 mL in 1 SYRINGE, GLASS
0078-0827-98000780827981 SYRINGE, GLASS in 1 CARTON (0078-0827-98) / .05 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0078-0827

Use it

Look up 0078-0827 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0827 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.